Convalescent phase sera from children infected with G12 rotavirus cross-neutralize rotavirus strains belonging to the Wa genogroup

Journal of General Virology

Volumn 91, Issue 7, 2010, Pages 1794-1799

  Sharma, Sumit ^a   Nakagomi, Toyoko ^b   Nakagomi, Osamu ^b   Paul, Vinod K ^a   Bhan, Maharaj K ^a   Ray, Pratima ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; GENOTYPE; HUMAN; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS STRAIN; BLOOD; CLASSIFICATION; GENETICS; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; VIROLOGY;

ROTAVIRUS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; HUMANS; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 77954149965     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.019489-0     Document Type: Article

References (37)

1. Arias, C. F., Lopez, S., Mascarenhas, J. D., Romero, P., Cano, P., Gabbay, Y. B., de Freitas, R. B. & Linhares, A. C. (1994). Neutralizing antibody immune response in children with primary and secondary rotavirus infections. Clin Diagn Lab Immunol 1, 89-94.
2. Bahl, R., Ray, P., Subodh, S., Shambharkar, P., Saxena, M., Parashar, U., Gentsch, J., Glass, R. & Bhan, M. K. (2005). Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 192, S114-S119.
3. Bernstein, D. I., Sack, D. A., Rothstein, E., Reisinger, K., Smith, V. E., O'Sullivan, D., Spriggs, D. R. & Ward, R. L. (1999). Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 354, 287-290.
4. Bhan, M. K., Lew, J. F., Sazawal, S., Das, B. K., Gentsch, J. R. & Glass, R. I. (1993). Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis 168, 282-287.
5. Bhandari, N., Sharma, P., Glass, R. I., Ray, P., Greenberg, H., Taneja, S., Saksena, M., Rao, C. D., Gentsch, J. R. & other authors (2006). Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine 24, 5817-5823.
6. Bhandari, N., Sharma, P., Taneja, S., Kumar, T., Rongsen-Chandola, T., Appaiahgari, M. B., Mishra, A., Singh, S. & Vrati, S. (2009). A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis 200, 421-429.
7. Brüssow, H., Clark, H. F. & Sidoti, J. (1991). Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central. J Clin Microbiol 29, 208-211.
8. Choi, A. H., McNeal, M. M., Basu, M., Flint, J. A., Stone, S. C., Clements, J. D., Bean, J. A., Poe, S. A., VanCott, J. L. & Ward, R. L. (2002). Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 20, 3310-3321.
9. Das, B. K., Gentsch, J. R., Cicirello, H. G., Woods, P. A., Gupta, A., Ramachandran, M., Kumar, R., Bhan, M. K. & Glass, R. I. (1994). Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 32, 1820-1822.
10. Glass, R. I., Bhan, M. K., Ray, P., Bahl, R., Parashar, U. D., Greenberg, H., Rao, C. D., Bhandari, N., Maldonado, Y. & other authors (2005). Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 192, S30-S35.
11. Glass, R. I., Parashar, U. D., Bresee, J. S., Turcios, R., Fischer, T. K., Widdowson, M., Jiang, B. & Gentsch, J. R. (2006). Rotavirus vaccines: current prospects and future challenges. Lancet 368, 323-332.
12. Heaton, P. M., Goveia, M. G., Miller, J. M., Offit, P. & Clark, H. F. (2005). Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 192, S17-S21.
13. Hoshino, Y. & Kapikian, A. Z. (1996). Classification of rotavirus VP4 and VP7 serotypes. Arch Virol Suppl 12, 99-111.
14. Hoshino, Y., Sereno, M. M., Midthun, K., Flores, J., Kapikian, A. Z. & Chanock, R. M. (1985). Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A 82, 8701-8704. (Pubitemid 16101111)
15. Jiang, B., Gentsch, J. R. & Glass, R. I. (2008). Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 26, 6754-6758.
16. Kirkwood, C. D. & Buttery, J. (2003). Rotavirus vaccines - an update. Expert Opin Biol Ther 3, 97-105.
17. Knowlton, D. R., Spector, D. M. & Ward, R. L. (1991). Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods 33, 127-134.
18. Kutsuzawa, T., Konno, T., Suzuki, H., Kapikian, A. Z., Ebina, T. & Ishida, N. (1982). Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16, 727-730. (Pubitemid 12029303)
19. Malik, J., Bhan, M. K. & Ray, P. (2008). Natural immunity to rotavirus infection in children. Indian J Biochem Biophys 45, 219-228.
20. Matthijnssens, J., Ciarlet, M., Heiman, E., Arijs, I., Delbeke, T., McDonald, S. M., Palombo, E. A., Iturriza-Gómara, M., Maes, P. & other authors (2008). Full genome-based classification of rotaviruses reveals a common origin between human Wa-like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 82, 3204-3219.
21. Offit, P. A. & Blavat, G. (1986). Identification of the two rotavirus genes determining neutralization specificities. J Virol 57, 376-378.
22. Parashar, U. D., Gibson, C. J., Bresse, J. S. & Glass, R. I. (2006). Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12, 304-306.
23. Rahman, M., Matthijnssens, J., Yang, X., Delbeke, T., Arijs, I., Taniguchi, K., Iturriza-Gomara, M., Iftekharuddin, N., Azim, T. & Van Ranst, M. (2007). Evolutionary history and global spread of the emerging G12 human rotaviruses. J Virol 81, 2382-2390.
24. Ramachandran, M., Vij, A., Kumar, R., Das, B. K., Gentsch, J. R., Bhan, M. K. & Glass, R. I. (1998). Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains. Clin Diagn Lab Immunol 5, 527-530.
25. Ray, P. G. & Kelkar, S. D. (2004). Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers. Clin Diagn Lab Immunol 11, 186-194.
26. Ray, P., Sharma, S., Agarwal, R. K., Longmei, K., Gentsch, J. R., Paul, V. K., Glass, R. I. & Bhan, M. K. (2007). First detection of G12 rotaviruses in newborns with neonatal rotavirus infection at All India Institute of Medical Sciences, New Delhi, India. J Clin Microbiol 45, 3824-3827.
27. Ruiz-Palacios, G. M., Perez-Schael, I., Velazquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P. & other authors (2006). Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354, 11-22.
28. Santos, N. & Hoshino, Y. (2005). Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15, 29-56.
29. Schumann, T., Hotzel, H., Otto, P. & Johne, R. (2009). Evidence of interspecies transmission and reassortment among avian group A rotaviruses. Virology 386, 334-343.
30. Sharma, S., Ray, P., Gentsch, J. R., Glass, R. I., Kalra, V. & Bhan, M. K. (2008). Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007. J Clin Microbiol 46, 1343-1348.
31. Sharma, S., Paul, V. K., Bhan, M. K. & Ray, P. (2009). Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain from Delhi, India. J Clin Microbiol 47, 3998-4005.
32. Uchida, R., Pandey, B. D., Sherchand, J. B., Ahmed, K., Yokoo, M., Nakagomi, T., Cuevas, L. E., Cunliffe, N. A., Hart, C. A. & Nakagomi, O. (2006). Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol 44, 3499-3505.
33. Ursu, K., Kisfali, P., Rigo, D., Ivanics, E., Erdelyi, K., Dan, A., Melegh, B., Martella, V. & Banyai, K. (2009). Molecular analysis of the VP7 gene of pheasant rotaviruses identifies a new genotype, designated G23. Arch Virol 154, 1365-1369.
34. Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M. J., Heyse, J. F., Goveia, M. G. & other authors (2006). Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354, 23-33.
35. Ward, R. L., Sander, D. S., Schiff, G. M. & Bernstein, D. I. (1990). Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis 162, 1298-1303.
36. Yu, J. & Langridge, W. H. (2001). A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 19, 548-552.
37. Zheng, B. J., Han, S. X., Yan, Y. K., Liang, X. R., Ma, G. Z., Yang, Y. & Ng, M. H. (1988). Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus. J Clin Microbiol 26, 1506-1512.